AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avita Therapeutics

1.120

+0.0050.45%

Volume:65.23K

Turnover:73.59K

Market Cap:170.76M

PE:-0.05

High:1.140

Open:1.130

Low:1.120

Close:1.115

52wk High:3.380

52wk Low:1.000

Shares:152.47M

Float Shares:5.34M

Volume Ratio:0.19

T/O Rate:1.22%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-20.508

EPS(LYR):-27.044

ROE:-1746.27%

ROA:-36.33%

PB:-18.11

PE(LYR):-0.04

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+1.74%

Capital Flow

Inflow:

Outflow:

News

Stock Track | Avita Therapeutics Plummets 22.58% on CEO Change and Q3 Revenue Guidance

Avita Medical Appoints Interim CEO, Issues Q3 Revenue Guidance; Shares Tumble 20%

MT Newswires Live

ASX Midday Sector Update: Energy Stocks Up, Healthcare Declines

MT Newswires Live

BUZZ-ASX-listed Avita Medical rises as data shows efficiency of its medical device

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AVH.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AVH.AU\",,,,,undefined,":{"symbol":"AVH.AU","market":"AU","secType":"STK","nameCN":"Avita Therapeutics","latestPrice":1.12,"timestamp":1770700320000,"preClose":1.115,"halted":0,"volume":65227,"delay":0,"changeRate":0.00448430493273553,"nameEN":"Avita Therapeutics","floatShares":5344505,"shares":152465555,"eps":-20.50839597242324,"marketStatus":"Closed","change":0.005,"latestTime":"02-10 16:12:00 AEDT","open":1.13,"high":1.14,"low":1.12,"amount":73593,"amplitude":0.017937,"askPrice":1.13,"askSize":6744,"bidPrice":1.115,"bidSize":3500,"shortable":3,"etf":0,"ttmEps":-20.50839597242324,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":5,"adr":0,"adrRate":8,"exchange":"ASX","adjPreClose":1.115,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.186397,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AVH.AU\",,,,,undefined,":{"symbol":"AVH.AU","floatShares":5344505,"roa":"-36.33%","roe":"-1746.27%","lyrEps":-27.043687,"volumeRatio":0.186397,"shares":152465555,"dividePrice":0,"high":1.14,"amplitude":0.017937,"preClose":1.115,"low":1.12,"week52Low":1,"pbRate":"-18.11","psRate":"1.67","week52High":3.38,"institutionHeld":0,"latestPrice":1.12,"committee":-0.316673,"eps":-20.50839597242324,"divideRate":0,"volume":65227,"delay":0,"ttmEps":-20.50839597242324,"open":1.13,"prevYearClose":1.05,"prevWeekClose":1.09,"prevMonthClose":1.23,"prevQuarterClose":1.05,"fiveDayClose":1.22,"twentyDayClose":1.055,"sixtyDayClose":1.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVH.AU\",params:#limit:5,,,undefined,":[{"date":"2023-08-10","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1691625600000,"name":null,"time":"","dateTimestamp":1691589600000,"actualEps":null},{"date":"2023-05-11","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1683763200000,"name":null,"time":"","dateTimestamp":1683727200000,"actualEps":null},{"date":"2023-02-23","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1677106800000,"name":null,"time":"","dateTimestamp":1677070800000,"actualEps":null},{"date":"2022-11-10","symbol":"AVH.AU","type":"earning","reportTimeType":"post","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1668034800000,"name":null,"time":"Post Market","dateTimestamp":1667998800000,"actualEps":null},{"date":"2022-08-11","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1660176000000,"name":null,"time":"","dateTimestamp":1660140000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVH.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVH.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1125214991","title":"Stock Track | Avita Therapeutics Plummets 22.58% on CEO Change and Q3 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1125214991","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125214991?lang=en_us&edition=fundamental","pubTime":"2025-10-17 07:28","pubTimestamp":1760657293,"startTime":"0","endTime":"0","summary":"Shares of Avita Therapeutics (ASX:AVH) plummeted 22.58% in Friday's trading session following the announcement of a leadership change and preliminary third-quarter revenue guidance. The significant...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AVH.AU"],"gpt_icon":0},{"id":"2576774070","title":"Avita Medical Appoints Interim CEO, Issues Q3 Revenue Guidance; Shares Tumble 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576774070","media":"MT Newswires Live","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576774070?lang=en_us&edition=fundamental","pubTime":"2025-10-17 07:24","pubTimestamp":1760657068,"startTime":"0","endTime":"0","summary":"Avita Medical  appointed Chairman Cary Vance as interim chief executive, effective immediately, succeeding Jim Corbett, according to a Friday filing with the Australian bourse.The board will engage an executive search firm to identify a permanent CEO from internal and external candidates, the filing said.In the same filing, the company said it anticipates preliminary revenue of around AU$17 million for the third quarter ended Sept. 30.The company's shares plummeted 20% in recent Friday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","AVH.AU"],"gpt_icon":0},{"id":"2567419405","title":"ASX Midday Sector Update: Energy Stocks Up, Healthcare Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2567419405","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567419405?lang=en_us&edition=fundamental","pubTime":"2025-09-15 11:30","pubTimestamp":1757907014,"startTime":"0","endTime":"0","summary":"Energy stocks advanced 0.5% at midday Monday, as investors look out for easing of the monetary policy in the US this week.Condor Energy  said a gas market and commercialization study for its Piedra Redonda gas field offshore Peru confirmed multiple pathways to monetization and identified immediate local and regional market opportunities, including gas-to-power and compressed natural gas supply to northern Peru and Ecuador.Meanwhile, healthcare fell more than 1%.Avita Medical  said it received the CE Mark approval under the European Union Medical Device Regulation for Recell GO, its burn and wound recovery medical product. It said that it will now begin commercialization of Recell GO in select European countries, including Germany, Italy, and the UK.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","HCSG","BK7142","AVH.AU","BK7067","CND.AU","BK7508"],"gpt_icon":0},{"id":"2565536167","title":"BUZZ-ASX-listed Avita Medical rises as data shows efficiency of its medical device","url":"https://stock-news.laohu8.com/highlight/detail?id=2565536167","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565536167?lang=en_us&edition=fundamental","pubTime":"2025-09-05 12:23","pubTimestamp":1757046184,"startTime":"0","endTime":"0","summary":"BUZZ-ASX-listed Avita Medical rises as data shows efficiency of its medical device** ASX-listed shares of AVITA Medical AVH.AX rises as much as 3% to A$1.37, highest since August 29** U.S.-based biotech firm says analysis of U.S. national burn registry data shows 36% shorter hospital stays in adults with deep second-degree burns treated with RECELL vs traditional skin grafting** RECELL System is U.S. FDA-approved device used to treat thermal burns, trauma wounds** AVH last up 1.1%, trimming YTD losses to 68.4%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nL4N3US09T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","RCEL","BK4139","BK7067","AVH.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AVH.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.017447}]}}